These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 24788096)

  • 21. Alpha₂-adrenergic agonists for the management of opioid withdrawal.
    Gowing L; Farrell M; Ali R; White JM
    Cochrane Database Syst Rev; 2016 May; 2016(5):CD002024. PubMed ID: 27140827
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Clonidine premedication for postoperative analgesia in children.
    Lambert P; Cyna AM; Knight N; Middleton P
    Cochrane Database Syst Rev; 2014 Jan; 2014(1):CD009633. PubMed ID: 24470114
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The USA experience with the clonidine transdermal therapeutic system.
    Burris JF
    Clin Auton Res; 1993 Dec; 3(6):391-6. PubMed ID: 8193527
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intentional intrathecal opioid detoxification in 3 patients: characterization of the intrathecal opioid withdrawal syndrome.
    Jackson TP; Lonergan DF; Todd RD; Martin PR
    Pain Pract; 2013 Apr; 13(4):297-309. PubMed ID: 22925591
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Antihypertensive effects of a new transdermal delivery system for clonidine in genetic and experimental hypertensive rats.
    Ishii R; Tagawa T; Ishida T; Naruse T
    Arzneimittelforschung; 1996 Mar; 46(3):261-8. PubMed ID: 8901146
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Utility of a transdermal delivery system for antihypertensive therapy. Part 1.
    Sclar DA; Skaer TL; Chin A; Okamoto MP; Gill MA
    Am J Med; 1991 Jul; 91(1A):50S-56S. PubMed ID: 1907801
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of transdermal clonidine treatment on withdrawal symptoms associated with smoking cessation. A randomized, controlled trial.
    Ornish SA; Zisook S; McAdams LA
    Arch Intern Med; 1988 Sep; 148(9):2027-31. PubMed ID: 3046542
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lofexidine (Lucemyra) for Treatment of Opioid Withdrawal Symptoms.
    Bryce C
    Am Fam Physician; 2019 Mar; 99(6):392-394. PubMed ID: 30874408
    [No Abstract]   [Full Text] [Related]  

  • 29. Development and validation of a paediatric oral formulation of clonidine hydrochloride.
    de Goede AL; Boedhram RR; Eckhardt M; Hanff LM; Koch BC; Vermaat CH; Vermes A
    Int J Pharm; 2012 Aug; 433(1-2):119-20. PubMed ID: 22580108
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Transdermal delivery of nicardipine: an approach to in vitro permeation enhancement.
    Aboofazeli R; Zia H; Needham TE
    Drug Deliv; 2002; 9(4):239-47. PubMed ID: 12511202
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluation of the Percutaneous Absorption of Ketamine HCl, Gabapentin, Clonidine HCl, and Baclofen, in Compounded Transdermal Pain Formulations, Using the Franz Finite Dose Model.
    Bassani AS; Banov D
    Pain Med; 2016 Feb; 17(2):230-8. PubMed ID: 26352507
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Effect of transdermal therapy with clonidine on suppression symptoms secondary to smoking cessation].
    Cervantes Escárcega JL; Guadalajara Boo JF
    Arch Inst Cardiol Mex; 1992; 62(5):435-40. PubMed ID: 1482222
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in plasma and urinary norepinephrine following transdermal clonidine in spontaneously hypertensive rats.
    Ishii R; Furuta M; Hashimoto M; Tagawa T; Naruse T; Hata T
    Arzneimittelforschung; 1998 Aug; 48(8):811-7. PubMed ID: 9748708
    [TBL] [Abstract][Full Text] [Related]  

  • 34. In vitro and in vivo characterization of a newly developed clonidine transdermal patch for treatment of attention deficit hyperactivity disorder in children.
    Ke GM; Wang L; Xue HY; Lu WL; Zhang X; Zhang Q; Guo HY
    Biol Pharm Bull; 2005 Feb; 28(2):305-10. PubMed ID: 15684489
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of two different galenic formulations of a transdermal clonidine system in the treatment of hypertension.
    Kolloch RE; Mehlburger L; Schumacher H; Göbel BO
    Clin Auton Res; 1993 Dec; 3(6):373-8. PubMed ID: 8193524
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The Effect of Adding Memantine to Clonidine in Reducing Withdrawal Symptoms in Opioid-Dependent Patients: A Double-Blind Randomized Controlled Trial.
    Kheirabadi G; Najafian N; Khodadadi F
    J Clin Psychopharmacol; 2021 Nov-Dec 01; 41(6):644-649. PubMed ID: 34559090
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Poly(2-hydroxy-3-phenoxypropylacrylate, 4-hydroxybutyl acrylate, dibutyl maleate) membrane controlled clonidine zero-order release.
    Zhan X; Chen S; Tang G; Mao Z
    Eur J Pharm Biopharm; 2007 Jun; 66(3):429-34. PubMed ID: 17196806
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Clonidine prophylaxis for narcotic and sedative withdrawal syndrome following laryngotracheal reconstruction.
    Deutsch ES; Nadkarni VM
    Arch Otolaryngol Head Neck Surg; 1996 Nov; 122(11):1234-8. PubMed ID: 8906060
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Perioperative aspirin and clonidine and risk of acute kidney injury: a randomized clinical trial.
    Garg AX; Kurz A; Sessler DI; Cuerden M; Robinson A; Mrkobrada M; Parikh CR; Mizera R; Jones PM; Tiboni M; Font A; Cegarra V; Gomez MF; Meyhoff CS; VanHelder T; Chan MT; Torres D; Parlow J; Clanchet Mde N; Amir M; Bidgoli SJ; Pasin L; Martinsen K; Malaga G; Myles P; Acedillo R; Roshanov PS; Walsh M; Dresser G; Kumar P; Fleischmann E; Villar JC; Painter T; Biccard B; Bergese S; Srinathan S; Cata JP; Chan V; Mehra B; Wijeysundera DN; Leslie K; Forget P; Whitlock R; Yusuf S; Devereaux PJ;
    JAMA; 2014 Dec; 312(21):2254-64. PubMed ID: 25399007
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Carbon nanotubes buckypapers for potential transdermal drug delivery.
    Schwengber A; Prado HJ; Zilli DA; Bonelli PR; Cukierman AL
    Mater Sci Eng C Mater Biol Appl; 2015 Dec; 57():7-13. PubMed ID: 26354234
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.